trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['tnbc', 'mbc', 'bcsm', 'breast']
goosebumps &amp; standing ovations for #her2 low #mbc #breastcancer with #tdxd clear clinically meaningful &amp; stat sig improvements with the adc vs inv choice chemo. os &amp; pfs benefit irrespective of #hormonepositive or #tnbc status #asco22 #bcsm 
Medical Oncologist. MA MD MRCP FRACP @uniofoxford @imperialcollege @rcplondon @theRACP Fellow @ucalgary